Click for best price
Glycosylated Biosimilars Market Size, Share 2023
Glycosylated Biosimilars include mA, EPO etc in this report.
This report aims to provide a comprehensive presentation of the global market for Glycosylated Biosimilars, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glycosylated Biosimilars. This report contains market size and forecasts of Glycosylated Biosimilars in global, including the following market information:
Global Glycosylated Biosimilars Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Glycosylated Biosimilars market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
mAb Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Glycosylated Biosimilars include Sandoz, Pfizer, Teva Pahrmaceutical, Celltrion, Biocon, Amgen, Samsung Biologics, Mylan and Dr. Reddy's Laboratories, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Glycosylated Biosimilars companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Glycosylated Biosimilars Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Glycosylated Biosimilars Market Segment Percentages, by Type, 2022 (%)
mAb
EPO
Global Glycosylated Biosimilars Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Glycosylated Biosimilars Market Segment Percentages, by Application, 2022 (%)
Oncology
Chronic Diseases
Autoimmune Diseases
Blood Disorders
Growth Hormone Deficiency
Infectious Diseases
Other Diseases
Global Glycosylated Biosimilars Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Glycosylated Biosimilars Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Glycosylated Biosimilars revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Glycosylated Biosimilars revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sandoz
Pfizer
Teva Pahrmaceutical
Celltrion
Biocon
Amgen
Samsung Biologics
Mylan
Dr. Reddy's Laboratories
Stada Arzneimittel AG
Outline of Major Chapters:
Chapter 1: Introduces the definition of Glycosylated Biosimilars, market overview.
Chapter 2: Global Glycosylated Biosimilars market size in revenue.
Chapter 3: Detailed analysis of Glycosylated Biosimilars company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Glycosylated Biosimilars in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Glycosylated Biosimilars Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
63 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Glycosylated Biosimilars Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Glycosylated Biosimilars Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Glycosylated Biosimilars Overall Market Size
2.1 Global Glycosylated Biosimilars Market Size: 2022 VS 2029
2.2 Global Glycosylated Biosimilars Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Glycosylated Biosimilars Players in Global Market
3.2 Top Global Glycosylated Biosimilars Companies Ranked by Revenue
3.3 Global Glycosylated Biosimilars Revenue by Companies
3.4 Top 3 and Top 5 Glycosylated Biosimilars Companies in Global Market, by Revenue in 2022
3.5 Global Companies Glycosylated Biosimilars Product Type
3.6 Tier 1, Tier 2 and Tier 3 Glycosylated Biosimilars Players in Global Market
3.6.1 List of Global Tier 1 Glycosylated Biosimilars Companies
3.6.2 List of Global Tier 2 and Tier 3 Glycosylated Biosimilars Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Glycosylated Biosimilars Market Size Markets, 2022 & 2029
4.1.2 mAb
4.1.3 EPO
4.2 By Type - Global Glycosylated Biosimilars Revenue & Forecasts
4.2.1 By Type - Global Glycosylated Biosimilars Revenue, 2018-2023
4.2.2 By Type - Global Glycosylated Biosimilars Revenue, 2024-2029
4.2.3 By Type - Global Glycosylated Biosimilars Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Glycosylated Biosimilars Market Size, 2022 & 2029
5.1.2 Oncology
5.1.3 Chronic Diseases
5.1.4 Autoimmune Diseases
5.1.5 Blood Disorders
5.1.6 Growth Hormone Deficiency
5.1.7 Infectious Diseases
5.1.8 Other Diseases
5.2 By Application - Global Glycosylated Biosimilars Revenue & Forecasts
5.2.1 By Application - Global Glycosylated Biosimilars Revenue, 2018-2023
5.2.2 By Application - Global Glycosylated Biosimilars Revenue, 2024-2029
5.2.3 By Application - Global Glycosylated Biosimilars Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Glycosylated Biosimilars Market Size, 2022 & 2029
6.2 By Region - Global Glycosylated Biosimilars Revenue & Forecasts
6.2.1 By Region - Global Glycosylated Biosimilars Revenue, 2018-2023
6.2.2 By Region - Global Glycosylated Biosimilars Revenue, 2024-2029
6.2.3 By Region - Global Glycosylated Biosimilars Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Glycosylated Biosimilars Revenue, 2018-2029
6.3.2 US Glycosylated Biosimilars Market Size, 2018-2029
6.3.3 Canada Glycosylated Biosimilars Market Size, 2018-2029
6.3.4 Mexico Glycosylated Biosimilars Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Glycosylated Biosimilars Revenue, 2018-2029
6.4.2 Germany Glycosylated Biosimilars Market Size, 2018-2029
6.4.3 France Glycosylated Biosimilars Market Size, 2018-2029
6.4.4 U.K. Glycosylated Biosimilars Market Size, 2018-2029
6.4.5 Italy Glycosylated Biosimilars Market Size, 2018-2029
6.4.6 Russia Glycosylated Biosimilars Market Size, 2018-2029
6.4.7 Nordic Countries Glycosylated Biosimilars Market Size, 2018-2029
6.4.8 Benelux Glycosylated Biosimilars Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Glycosylated Biosimilars Revenue, 2018-2029
6.5.2 China Glycosylated Biosimilars Market Size, 2018-2029
6.5.3 Japan Glycosylated Biosimilars Market Size, 2018-2029
6.5.4 South Korea Glycosylated Biosimilars Market Size, 2018-2029
6.5.5 Southeast Asia Glycosylated Biosimilars Market Size, 2018-2029
6.5.6 India Glycosylated Biosimilars Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Glycosylated Biosimilars Revenue, 2018-2029
6.6.2 Brazil Glycosylated Biosimilars Market Size, 2018-2029
6.6.3 Argentina Glycosylated Biosimilars Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Glycosylated Biosimilars Revenue, 2018-2029
6.7.2 Turkey Glycosylated Biosimilars Market Size, 2018-2029
6.7.3 Israel Glycosylated Biosimilars Market Size, 2018-2029
6.7.4 Saudi Arabia Glycosylated Biosimilars Market Size, 2018-2029
6.7.5 UAE Glycosylated Biosimilars Market Size, 2018-2029
7 Glycosylated Biosimilars Companies Profiles
7.1 Sandoz
7.1.1 Sandoz Company Summary
7.1.2 Sandoz Business Overview
7.1.3 Sandoz Glycosylated Biosimilars Major Product Offerings
7.1.4 Sandoz Glycosylated Biosimilars Revenue in Global Market (2018-2023)
7.1.5 Sandoz Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Company Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Glycosylated Biosimilars Major Product Offerings
7.2.4 Pfizer Glycosylated Biosimilars Revenue in Global Market (2018-2023)
7.2.5 Pfizer Key News & Latest Developments
7.3 Teva Pahrmaceutical
7.3.1 Teva Pahrmaceutical Company Summary
7.3.2 Teva Pahrmaceutical Business Overview
7.3.3 Teva Pahrmaceutical Glycosylated Biosimilars Major Product Offerings
7.3.4 Teva Pahrmaceutical Glycosylated Biosimilars Revenue in Global Market (2018-2023)
7.3.5 Teva Pahrmaceutical Key News & Latest Developments
7.4 Celltrion
7.4.1 Celltrion Company Summary
7.4.2 Celltrion Business Overview
7.4.3 Celltrion Glycosylated Biosimilars Major Product Offerings
7.4.4 Celltrion Glycosylated Biosimilars Revenue in Global Market (2018-2023)
7.4.5 Celltrion Key News & Latest Developments
7.5 Biocon
7.5.1 Biocon Company Summary
7.5.2 Biocon Business Overview
7.5.3 Biocon Glycosylated Biosimilars Major Product Offerings
7.5.4 Biocon Glycosylated Biosimilars Revenue in Global Market (2018-2023)
7.5.5 Biocon Key News & Latest Developments
7.6 Amgen
7.6.1 Amgen Company Summary
7.6.2 Amgen Business Overview
7.6.3 Amgen Glycosylated Biosimilars Major Product Offerings
7.6.4 Amgen Glycosylated Biosimilars Revenue in Global Market (2018-2023)
7.6.5 Amgen Key News & Latest Developments
7.7 Samsung Biologics
7.7.1 Samsung Biologics Company Summary
7.7.2 Samsung Biologics Business Overview
7.7.3 Samsung Biologics Glycosylated Biosimilars Major Product Offerings
7.7.4 Samsung Biologics Glycosylated Biosimilars Revenue in Global Market (2018-2023)
7.7.5 Samsung Biologics Key News & Latest Developments
7.8 Mylan
7.8.1 Mylan Company Summary
7.8.2 Mylan Business Overview
7.8.3 Mylan Glycosylated Biosimilars Major Product Offerings
7.8.4 Mylan Glycosylated Biosimilars Revenue in Global Market (2018-2023)
7.8.5 Mylan Key News & Latest Developments
7.9 Dr. Reddy's Laboratories
7.9.1 Dr. Reddy's Laboratories Company Summary
7.9.2 Dr. Reddy's Laboratories Business Overview
7.9.3 Dr. Reddy's Laboratories Glycosylated Biosimilars Major Product Offerings
7.9.4 Dr. Reddy's Laboratories Glycosylated Biosimilars Revenue in Global Market (2018-2023)
7.9.5 Dr. Reddy's Laboratories Key News & Latest Developments
7.10 Stada Arzneimittel AG
7.10.1 Stada Arzneimittel AG Company Summary
7.10.2 Stada Arzneimittel AG Business Overview
7.10.3 Stada Arzneimittel AG Glycosylated Biosimilars Major Product Offerings
7.10.4 Stada Arzneimittel AG Glycosylated Biosimilars Revenue in Global Market (2018-2023)
7.10.5 Stada Arzneimittel AG Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Glycosylated Biosimilars Market Opportunities & Trends in Global Market
Table 2. Glycosylated Biosimilars Market Drivers in Global Market
Table 3. Glycosylated Biosimilars Market Restraints in Global Market
Table 4. Key Players of Glycosylated Biosimilars in Global Market
Table 5. Top Glycosylated Biosimilars Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Glycosylated Biosimilars Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Glycosylated Biosimilars Revenue Share by Companies, 2018-2023
Table 8. Global Companies Glycosylated Biosimilars Product Type
Table 9. List of Global Tier 1 Glycosylated Biosimilars Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Glycosylated Biosimilars Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Glycosylated Biosimilars Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Glycosylated Biosimilars Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Glycosylated Biosimilars Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Glycosylated Biosimilars Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Glycosylated Biosimilars Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Glycosylated Biosimilars Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Glycosylated Biosimilars Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Glycosylated Biosimilars Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Glycosylated Biosimilars Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Glycosylated Biosimilars Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Glycosylated Biosimilars Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Glycosylated Biosimilars Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Glycosylated Biosimilars Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Glycosylated Biosimilars Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Glycosylated Biosimilars Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Glycosylated Biosimilars Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Glycosylated Biosimilars Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Glycosylated Biosimilars Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Glycosylated Biosimilars Revenue, (US$, Mn), 2024-2029
Table 30. Sandoz Company Summary
Table 31. Sandoz Glycosylated Biosimilars Product Offerings
Table 32. Sandoz Glycosylated Biosimilars Revenue (US$, Mn) & (2018-2023)
Table 33. Sandoz Key News & Latest Developments
Table 34. Pfizer Company Summary
Table 35. Pfizer Glycosylated Biosimilars Product Offerings
Table 36. Pfizer Glycosylated Biosimilars Revenue (US$, Mn) & (2018-2023)
Table 37. Pfizer Key News & Latest Developments
Table 38. Teva Pahrmaceutical Company Summary
Table 39. Teva Pahrmaceutical Glycosylated Biosimilars Product Offerings
Table 40. Teva Pahrmaceutical Glycosylated Biosimilars Revenue (US$, Mn) & (2018-2023)
Table 41. Teva Pahrmaceutical Key News & Latest Developments
Table 42. Celltrion Company Summary
Table 43. Celltrion Glycosylated Biosimilars Product Offerings
Table 44. Celltrion Glycosylated Biosimilars Revenue (US$, Mn) & (2018-2023)
Table 45. Celltrion Key News & Latest Developments
Table 46. Biocon Company Summary
Table 47. Biocon Glycosylated Biosimilars Product Offerings
Table 48. Biocon Glycosylated Biosimilars Revenue (US$, Mn) & (2018-2023)
Table 49. Biocon Key News & Latest Developments
Table 50. Amgen Company Summary
Table 51. Amgen Glycosylated Biosimilars Product Offerings
Table 52. Amgen Glycosylated Biosimilars Revenue (US$, Mn) & (2018-2023)
Table 53. Amgen Key News & Latest Developments
Table 54. Samsung Biologics Company Summary
Table 55. Samsung Biologics Glycosylated Biosimilars Product Offerings
Table 56. Samsung Biologics Glycosylated Biosimilars Revenue (US$, Mn) & (2018-2023)
Table 57. Samsung Biologics Key News & Latest Developments
Table 58. Mylan Company Summary
Table 59. Mylan Glycosylated Biosimilars Product Offerings
Table 60. Mylan Glycosylated Biosimilars Revenue (US$, Mn) & (2018-2023)
Table 61. Mylan Key News & Latest Developments
Table 62. Dr. Reddy's Laboratories Company Summary
Table 63. Dr. Reddy's Laboratories Glycosylated Biosimilars Product Offerings
Table 64. Dr. Reddy's Laboratories Glycosylated Biosimilars Revenue (US$, Mn) & (2018-2023)
Table 65. Dr. Reddy's Laboratories Key News & Latest Developments
Table 66. Stada Arzneimittel AG Company Summary
Table 67. Stada Arzneimittel AG Glycosylated Biosimilars Product Offerings
Table 68. Stada Arzneimittel AG Glycosylated Biosimilars Revenue (US$, Mn) & (2018-2023)
Table 69. Stada Arzneimittel AG Key News & Latest Developments
List of Figures
Figure 1. Glycosylated Biosimilars Segment by Type in 2022
Figure 2. Glycosylated Biosimilars Segment by Application in 2022
Figure 3. Global Glycosylated Biosimilars Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Glycosylated Biosimilars Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Glycosylated Biosimilars Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Glycosylated Biosimilars Revenue in 2022
Figure 8. By Type - Global Glycosylated Biosimilars Revenue Market Share, 2018-2029
Figure 9. By Application - Global Glycosylated Biosimilars Revenue Market Share, 2018-2029
Figure 10. By Type - Global Glycosylated Biosimilars Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Glycosylated Biosimilars Revenue Market Share, 2018-2029
Figure 12. By Application - Global Glycosylated Biosimilars Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Glycosylated Biosimilars Revenue Market Share, 2018-2029
Figure 14. By Region - Global Glycosylated Biosimilars Revenue Market Share, 2018-2029
Figure 15. By Country - North America Glycosylated Biosimilars Revenue Market Share, 2018-2029
Figure 16. US Glycosylated Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Glycosylated Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Glycosylated Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Glycosylated Biosimilars Revenue Market Share, 2018-2029
Figure 20. Germany Glycosylated Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 21. France Glycosylated Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Glycosylated Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Glycosylated Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Glycosylated Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Glycosylated Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Glycosylated Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Glycosylated Biosimilars Revenue Market Share, 2018-2029
Figure 28. China Glycosylated Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Glycosylated Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Glycosylated Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Glycosylated Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 32. India Glycosylated Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Glycosylated Biosimilars Revenue Market Share, 2018-2029
Figure 34. Brazil Glycosylated Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Glycosylated Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Glycosylated Biosimilars Revenue Market Share, 2018-2029
Figure 37. Turkey Glycosylated Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Glycosylated Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Glycosylated Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Glycosylated Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 41. Sandoz Glycosylated Biosimilars Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Pfizer Glycosylated Biosimilars Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Teva Pahrmaceutical Glycosylated Biosimilars Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Celltrion Glycosylated Biosimilars Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Biocon Glycosylated Biosimilars Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Amgen Glycosylated Biosimilars Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Samsung Biologics Glycosylated Biosimilars Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Mylan Glycosylated Biosimilars Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Dr. Reddy's Laboratories Glycosylated Biosimilars Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Stada Arzneimittel AG Glycosylated Biosimilars Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
